Elekta AB (publ) (OTCMKTS:EKTAY) Hits New 12-Month Low – Should You Sell?

Shares of Elekta AB (publ) (OTCMKTS:EKTAY) reached a new 52-week low during mid-day trading on Wednesday . The stock traded as low as $5.73 and last traded at $5.74, with a volume of 12359 shares changing hands. The stock had previously closed at $5.87.

Elekta AB (publ) Stock Performance

The company has a debt-to-equity ratio of 0.45, a quick ratio of 0.74 and a current ratio of 0.99. The business has a 50-day moving average price of $6.45 and a 200 day moving average price of $6.62. The stock has a market capitalization of $2.19 billion, a P/E ratio of 17.94 and a beta of 1.23.

Elekta AB (publ) (OTCMKTS:EKTAY) last issued its earnings results on Wednesday, August 28th. The company reported $0.04 earnings per share (EPS) for the quarter. The business had revenue of $359.76 million during the quarter. Elekta AB (publ) had a net margin of 6.25% and a return on equity of 12.23%. As a group, sell-side analysts forecast that Elekta AB will post 0.41 EPS for the current fiscal year.

Elekta AB (publ) Company Profile

Elekta AB (publ), a medical technology company, provides clinical solutions for treating cancer and brain disorders worldwide. The company offers Versa HD, a brain metastases solution; Elekta Unity for real-time MR visualization; Elekta Harmony, a linear accelerator; Elekta Infinity for treating a range of patients with simple-to-complex radiotherapy needs; Elekta Synergy, a digital accelerator for image guided radiation therapy; treatment and workflow management solutions; radiation and medical oncology; and other patient services.